Bb Biotech Ag Has Increased Its Tesaro (TSRO) Stake; GROWGENERATION (GRWG) Shorts Decreased By 33.85%

Tesaro, Inc. (NASDAQ:TSRO) Logo

GROWGENERATION CORP (OTCMKTS:GRWG) had a decrease of 33.85% in short interest. GRWG’s SI was 12,900 shares in February as released by FINRA. Its down 33.85% from 19,500 shares previously. With 220,700 avg volume, 0 days are for GROWGENERATION CORP (OTCMKTS:GRWG)’s short sellers to cover GRWG’s short positions. The stock increased 4.32% or $0.14 during the last trading session, reaching $3.38. About 105,831 shares traded or 9.28% up from the average. GrowGeneration Corp. (OTCMKTS:GRWG) has 0.00% since February 11, 2018 and is . It has by 0.00% the S&P500.

Bb Biotech Ag increased Tesaro Inc. (TSRO) stake by 20.81% reported in 2018Q3 SEC filing. Bb Biotech Ag acquired 505,000 shares as Tesaro Inc. (TSRO)’s stock rose 103.15%. The Bb Biotech Ag holds 2.93M shares with $114.37M value, up from 2.43 million last quarter. Tesaro Inc. now has $4.14B valuation. It closed at $74.96 lastly. It is down 11.09% since February 11, 2018 and is downtrending. It has underperformed by 11.09% the S&P500. Some Historical TSRO News: 08/05/2018 – AstraZeneca: EU Approves Lynparza Tablets for Relapsed Ovarian Cancer; 23/05/2018 – MERCK & CO INC – KEYTRUDA HAS NOW DEMONSTRATED AN IMPROVED SURVIVAL BENEFIT IN ADVANCED NSCLC IN FIVE PHASE 3 TRIALS; 30/04/2018 – Merck Has Submitted Keytruda Combination For FDA Approval — MarketWatch; 17/05/2018 – Oncolytics Biotech® Announces Collaboration with Merck and Northwestern University Combining Keytruda® and REOLYSIN® in a Phase 2 Second Line Pancreatic Cancer Study; 17/04/2018 – Dynavax Provides New Durability of Response Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Melanoma at the 2; 16/04/2018 – Dynavax Reports Interim Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck; 08/05/2018 – ASTRAZENECA PLC AZN.L – EUROPEAN MEDICINES AGENCY (EMA) HAS APPROVED LYNPARZA (OLAPARIB) TABLETS; 17/05/2018 – Eisai Announces Data at ASCO 2018 Annual Meeting Showcasing LENVIMA® (lenvatinib) and KEYTRUDA® (pembrolizumab) Combination Therapy Under Strategic Oncology Collaboration with Merck; 17/04/2018 – Dynavax Provides New Durability of Response Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Melanoma at the 2018 American Association for Cancer Research Annual Meeting; 24/04/2018 – TESARO REPORTS POS TOP-LINE RESULTS FROM QUADRA TRIAL OF ZEJULA

More notable recent GrowGeneration Corp. (OTCMKTS:GRWG) news were published by: Seekingalpha.com which released: “GrowGeneration acquires HeavyGardens.com – Seeking Alpha” on September 17, 2018, also Seekingalpha.com with their article: “GrowGeneration purchases Santa Rosa Hydroponics and Grower Supply – Seeking Alpha” published on July 16, 2018, Investorideas.com published: “Investor ideas stock news, podcasts and videos for investing in blockchain , cannabis, crypto, technology, AI and IoT, mining, sports, biotech, water, renewable energy, beverage, entertainment – InvestorIdeas.com” on February 11, 2019. More interesting news about GrowGeneration Corp. (OTCMKTS:GRWG) were released by: Seekingalpha.com and their article: “GrowGeneration Is Building Its Base For Growth – Seeking Alpha” published on November 13, 2017 as well as Seekingalpha.com‘s news article titled: “GrowGeneration Buys Hydroponic Store In Seattle – Seeking Alpha” with publication date: May 23, 2017.

GrowGeneration Corp., through its subsidiaries, operates retail hydroponic stores. The company has market cap of $94.80 million. It offers farming soil, hydroponic equipment, lighting, plant nutrients, and various other products. It currently has negative earnings. The firm serves home growers of organic vegetables and fruits, do-it yourselfers, and growers in the cannabis related markets.

Since September 1, 2018, it had 0 insider buys, and 2 sales for $16,297 activity. Another trade for 72 shares valued at $2,336 was sold by Oliveira Orlando. Huber Martin H. Jr. sold $13,961 worth of stock or 371 shares.

Investors sentiment increased to 1.14 in Q3 2018. Its up 0.21, from 0.93 in 2018Q2. It improved, as 35 investors sold TSRO shares while 37 reduced holdings. 34 funds opened positions while 48 raised stakes. 62.87 million shares or 7.32% more from 58.58 million shares in 2018Q2 were reported. Miracle Mile Advsr Limited Co reported 0.03% stake. Oppenheimer And Inc accumulated 0.01% or 8,881 shares. Nea Mngmt Ltd Company invested in 10.42 million shares. Orbimed Advsrs Llc has invested 0.03% in Tesaro, Inc. (NASDAQ:TSRO). Nomura Holdings Inc has invested 0.01% in Tesaro, Inc. (NASDAQ:TSRO). Employees Retirement Of Texas invested 0.01% in Tesaro, Inc. (NASDAQ:TSRO). Goldman Sachs Grp invested in 699,508 shares. Hsbc Hldgs Plc invested in 19,489 shares or 0% of the stock. Girard Prns Limited holds 350 shares or 0% of its portfolio. Next Grp invested in 100 shares or 0% of the stock. Eulav Asset Management holds 520,000 shares or 0.87% of its portfolio. America First Advsrs Llc owns 0.01% invested in Tesaro, Inc. (NASDAQ:TSRO) for 1,000 shares. Great West Life Assurance Can invested in 0% or 2,986 shares. Advisors Asset invested in 1,237 shares. Metropolitan Life Insur has invested 0% of its portfolio in Tesaro, Inc. (NASDAQ:TSRO).

Tesaro, Inc. (NASDAQ:TSRO) Institutional Positions Chart